TGen and USC researchers find genetic markers to help figh... ( PHOENIX Ariz. June 16 2009 Transla...)

TGen and USC researchers find genetic markers to help fight diabetes

Date:6/16/2009

PHOENIX, Ariz. June 16, 2009 Translational Genomics Research Institute (TGen) scientists have identified five genetic biomarkers that could help lead to improved treatments, with fewer side-effects, for patients with diabetes.

TGen Senior Investigator Dr. Johanna DiStefano presented the findings in New Orleans on June 6, 2009, at the 69th Scientific Sessions of the American Diabetes Association.

"We identified genetic variants that may predict how well someone will respond to the common anti-diabetes drug, Actos,'' said Dr. DiStefano, Director of TGen's Diabetes, Cardiovascular & Metabolic Diseases Division. "The implications of these findings include determining which patients will best respond to the drug for the prevention or treatment of diabetes. In addition, this work lays the foundation for personalized medicine for patients with this disease.''

Personalized medicine involves the rapid application of laboratory discoveries to therapies, depending on the individual genetic make-up of each patient.

A TGen-led team, working with scientists from the University of Southern California's Keck School of Medicine, investigated why as many as 30-40 percent of diabetes patients treated with thiazolidinediones (TZDs), such as Actos, fail to respond to the drug with the expected improvement in insulin sensitivity.

TZDs are a class of insulin-sensitizing drugs used to treat type 2 diabetes mellitus (T2DM). TZDs are agonists for the nuclear receptor peroxisome proliferator-activated receptor-g (PPARG). Although the exact mechanism by which TZDs act is not yet known, data indicate that TZDs improve insulin sensitivity by direct and indirect effects on adipose tissue and muscle. TZD therapy can significantly lower diabetes incidence in at-risk subjects, suggesting this treatment may be an effective means to prevent the disease.

Previously, TGen and Keck investigators found that genetic variations in the PPARG gene w
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Vanderbilt researchers pioneer an advanced sepsis detection and management system
2. USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
3. Researchers identify 4 new targets for breast cancer
4. Researchers at Case Western Reserve discover a new way the body fights fungal infection
5. Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers
6. Researchers identify four new targets for breast cancer
7. VBI researchers develop new method for breast cancer biomarker discovery
8. Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers
9. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
10. Researchers work to boost effectiveness of the flu vaccine
11. Researchers develop the first climate-based model to predict Dengue fever outbreaks

Post Your Comments:

(Date:12/3/2009)... The Lifestyle Advisors at V... Gifts to ease the stress of finding that perfect ...the DIY treatments in health, fitness and wellness...e on time and within budget. , ...son mySpaShop (mSS), has gathered an assortment ...

(Date:12/3/2009)... Mailing a five pound gift a...llars for postage. Now the worldwide postage is f... gift book purchased online at www.oakanahouse.co... 2009 -- Mailing a five pound gift to Paris, Perth...ostage. But that,s 40 dollars they can keep in th...

(Date:12/2/2009)... , GRAND RAPIDS, Mich., Dec. 3 /PRNewswire/...s have determined precisely how the plant hormone ...o help plants respond to environmental stresses su... in the journal Nature , could help engineer crop...ld and combat global food shortages. The findings...

(Date:12/2/2009)... , NEW YORK, Dec. 2 Re...h report is available in its catalogue: ,, Poi...nker.com/p0166822/Point-of-Care-Diagnostics.html ...he point of care (POC) diagnostics industry ,, .... POC diagnostics industry ,, Covers federal r...

(Date:12/2/2009)... , BOSTON, Dec. 2 ...site traffic rises 8%. According to Coremetrics, ...ose 13.7 percent on Cyber Monday compared to Cyber...oston,s Bella Sante Day Spas who reported today ...onday Internet sales rose 59%" - said Tiffany Amor...

[0] Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments [0] Greg Lawson Americana Photography Gift Books Now Offered with Free Shipping Worldwide [1] VAI Researchers Find Long Awaited Key to Creating Drought Resistant Crops [0] Reportlinker Adds Point of Care Diagnostics [0] The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%.

...rn premature and more than one in ten infants in ...e of the common problems associated with premature...rity (OOP). It can cause bone fractures and ricket...emies bones stronger. Dr. Dan Nemet and his partne...

...hildren are exposed to peanuts and have an allergi... decade, despite recommendations that at-risk fami... first three years of life, according to research ...age of first peanut exposure and reaction were 14 ...

...c. 4, 2007 The High School Musical Rockerz Jammin...n Doll may be what kids want most this holiday sea...and other popular toys are used, a season of joy m...earchers warn that many emit sounds at decibel lev...

...lso available in Spanish . , The study, carried...rsity of Granada , consisted of an analysis of hea...d emergency departments in Spanish hospitals. The ...e link with a 24h translation service or provide s...

... that only vertebrates have sophisticated adaptive...inst many pathogens after being infected by them j...s out that many insects also have a form of immune...at the recent conference on Innate Immunity and th...

... Environmental,Protection Agency Region 5 has awar...th. The grant will fund coalitions in Cleveland an...programs in their schools., The coalitions are th...tions have done extensive work to improve,conditio...

Other Medicine News:Health News:Tel Aviv University gives preemies a fighting chance 2 Health News:Research finds allergic children exposed to peanuts at younger ages despite recommendations to avoid 2 Health News:Greater parental guidance suggested for noisy toy use 2 Health News:Emergency departments should offer immigrants translation, according to a study 2 Health News:Violent sex acts boost insect's immunity system 2 Health News:Violent sex acts boost insect's immunity system 3

Tel Aviv University gives preemies a fighting chance Research finds allergic children exposed to peanuts at younger ages despite recommendations to avoid Greater parental guidance suggested for noisy toy use Emergency departments should offer immigrants translation, according to a study Violent sex acts boost insect's immunity system EPA Awards $55,000 Grant to Ohio Health Department for Healthful Schools Program

(Date:12/3/2009)... , HELSINKI, December 3 /PRNewswire/ ...ly proven success in their field, Lightlake Therap... to begin selecting and gene testing,subjects for ...for what the,World Health Organisation has describ...esity. , A Phase II trial for the everyda...

(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlin...t is available in its catalogue: ,, EEG/EMG/B...,, http://www.reportlinker.com/p0164319/EEG/EM....html ,, Steep rise in obesity, cardiovascular...ectroencephalograph (EEG) diagnostic and monitorin...

(Date:12/2/2009)... ST. LOUIS, Dec. 2 KV Ph...at that it has entered into an employment agreemen...er David A. Van Vliet with a term through December...sident and Chief Executive Officer since December ...inuity of senior leadership as the Company seeks t...

Breaking Medicine Technology:Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2 Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3 Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4 Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7 Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8 KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet 2 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 1 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 2 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 3 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 4 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 5 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 6 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 7 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 8 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 9 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 10 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 11 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 12 Helix BioPharma Corp Announces Fiscal 2009 Results 5849 13 More Than 250 West Philadelphia Men Women and Children are Expected to Attend Wellness for Life Event 60355 1 More Than 250 West Philadelphia Men Women and Children are Expected to Attend Wellness for Life Event 60355 2 New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 1 New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 2 New Isolation Valves With Inert Body And Diaphragm Materials Added To Gems Family 60353 3

[0] Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland [0] Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends [0] KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet

... , , , , Company to Submit a Supplemental New D..., , FRAZER, Pa., April 6 Cephalon, Inc . (Nasda...a phase three clinical trial of NUVIGIL(R) (armoda... sleepiness associated with jet lag disorder. Bas...lemental New Drug Application with the U.S. Food a...

...SPRING, Md., April 2 Novo Nordisk today announced...ory Committee of the United States Food and Drug A...of questions related to liraglutide, a once-daily ... voted on questions related to the risk profile of...ory Committee members supported that appropriate e...

Other Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2 Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3 Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2 Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3

Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes

Filta-Therm® with CO₂ Port and Flextube Patient Connection

Filta-Therm®

...se hygroscopic condenser humidifiers (HCH) capture...n them in the inspired gas. Small and compact, the...and hygroscopic benefits. Depending on the tidal v...ll-volume model., ,The adult HCH is ideal for pat...

Medicine Products:

Filta-Therm® with CO₂ Port and Flextube Patient Connection Filta-Therm®Type II Small Volume HCH W/ Omniflex Connector HCH, Type I Adult

TGen and USC researchers find genetic markers to help figh...( PHOENIX Ariz. June 16 2009 Transla...),Health